Neutropenic splenomegaly
ICD-10 D73.81 is a billable code used to indicate a diagnosis of neutropenic splenomegaly.
Neutropenic splenomegaly is a condition characterized by the enlargement of the spleen (splenomegaly) in patients who have neutropenia, which is a lower-than-normal number of neutrophils, a type of white blood cell essential for fighting infections. This condition can arise from various underlying causes, including bone marrow disorders, autoimmune diseases, infections, and certain medications that suppress bone marrow function. The spleen plays a crucial role in filtering blood and managing immune responses, and its enlargement can lead to complications such as hypersplenism, where the spleen overactively removes blood cells, further exacerbating neutropenia. Clinically, patients may present with symptoms such as fatigue, recurrent infections, and abdominal discomfort due to splenic enlargement. Diagnosis typically involves blood tests to assess white blood cell counts, imaging studies to evaluate spleen size, and possibly bone marrow biopsies to determine the underlying cause of neutropenia. Management focuses on treating the underlying condition, monitoring blood counts, and addressing any complications arising from splenomegaly.
Detailed blood work results, including neutrophil counts and bone marrow findings.
Patients with chronic neutropenia due to bone marrow disorders or autoimmune conditions.
Ensure clear documentation of the relationship between neutropenia and splenomegaly.
Comprehensive patient history and physical examination findings related to splenomegaly.
Patients presenting with recurrent infections and splenomegaly.
Document any associated symptoms and the impact on the patient's overall health.
Used to evaluate neutrophil levels in patients with suspected neutropenia.
Document the reason for the CBC and any relevant clinical findings.
Hematologists should ensure that the differential count is clearly documented.
Neutropenic splenomegaly can be caused by various factors, including bone marrow disorders, autoimmune diseases, and certain infections that lead to decreased neutrophil production and splenic enlargement.
